Company intelligence / Profile preview

Trigen Pharma

Ownership: Private
Development stage: Commercial

Overview

Trigen Pharma has established itself as a leading player in the Pakistani pharmaceutical industry with a focus on cardiology, oncology support, gastrointestinal disorders, and male health. Its flagship products include TriCardin for cardiovascular treatment, RH2 for cancer support/chemotherapy relief, Monacolin-k for cholesterol management, Jinghua Weikang capsule for peptic ulcers/H. pylori inhibition, and Libogen Capsule for male sexual health. The company collaborates internationally to bring research-backed medicines to Pakistan.

Therapeutic areas: OncologyCardiovascularGastroenterologyMen's Health
Modalities: Small moleculesPhytopharmaceuticals (plant-derived medicines)Traditional Chinese Medicine (TCM)
Industry: Biotech

Drug pipeline

1 asset

Libogen

Unknown

Partnerships

Agreements with leading global companies in pharmaceuticals, phytopharmaceuticals & biotech sectors

Beyond the preview

Go deeper on Trigen Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trigen Pharma.

Explore the full profile